European Companies Search Engine

Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Abbvie A/S, Copenhagen, Denmark

Watch
Abbvie A/S

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Create Dossier
Abbvie A/S

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Abbvie A/S
WCA Pharmaceuticals A/S
Allergan Aesthetics A/S

Identification

Cvrcom
CVR 34462828
Lei
5493008LYJEW5J212O93
EUID
DKCVR.34462828

Address

Titangade 11, 2200 København, Denmark

Corporate purpose

46.46.20
Wholesale of medical and hospital supplies

The company's purpose is to conduct trade in pharmaceutical, hospital and diagnostics products and to develop, produce and market technology and know-how in connection therewith. In addition, the company may provide services and assistance, including administrative, operational, financial, business, scientific or industrial in connection with the company's purposes, to third parties, shareholders, subsidiaries or affiliated companies.

Financial performance

Earnings

For this company, Earnings numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Total assets

For this company, Total assets numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Persons

Network

Loading network

Legal Structure

Current legal representatives Legal form information Premium
Premium
1Chair of the board
2Director
6Member of the board
2Auditor
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more

Learn more View plans
CSV export

Investigative Journalism

Uncover International Corporate Connections with our Free Investigative-Account

Ownership relations Premium + Ownership & Flags add-on
Premium + Ownership & Flags add-on
Shareholders and Investors
2 known active shareholders
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more

Learn more View plans

Financials

Key Performance Indicators Financial · Mktg & Tech Premium
Premium
Base/share capital
Total assets
Earnings
Earnings CAGR
Revenue
Revenue CAGR
Return on sales
Equity
Equity ratio
Return on equity
Employee number
Revenue per employee
Taxes
Tax ratio
Cash on hand
Receivables
Liabilities
Wages and salaries
Average salaries per employee
Upgrade to unlock all features

Premium plans starting from €49/month

Learn more

Learn more View plans

Publications

29 Jun 2026
Annual report for the year ending 31/12/2025
22 Jun 2026
Annual report for the year ending 31/12/2025
26 Jun 2025
Annual report for the year ending 31/12/2024
21 Jun 2024
Annual report for the year ending 31/12/2023
11 Mar 2024
Address
16 Feb 2024
Member of the board: Shitra I. A. Blancas · No longer Member of the board: Emilie C. Demare
1 Feb 2024
No longer Member of the board: Emilie C. Demare
1 Feb 2024
Member of the board: Shitra I. A. Blancas
21 Aug 2023
Member of the board: Matthew Robert Iles · No longer Member of the board: Linn K. Mandahl
15 Aug 2023
No longer Chair of the board: Linn K. Mandahl
15 Aug 2023
Chair of the board: Matthew Robert Iles
7 Aug 2023
Company statute
26 Jun 2023
Annual report for the year ending 31/12/2022
10 Jun 2022
Annual report for the year ending 31/12/2021
1 Apr 2022
Member of the board: Arnaud Coint-Bavarot · No longer Member of the board: Thea Larsen · Proxy policy · Company statute
1 Apr 2022
Chair of the board: Linn K. Mandahl
1 Apr 2022
No longer Chair of the board: Robert A. Michael
1 Apr 2022
No longer Member of the board: Thea Larsen
1 Apr 2022
Member of the board: Emilie C. Demare
1 Apr 2022
Member of the board: Arnaud Coint-Bavarot
1 Apr 2022
Member of the board: Jens Lange
1 Apr 2022 via Allergan ApS
Shareholding, No longer Voting rights: Allergan ApS
31 Mar 2022
No longer Member of the board: Linn K. Mandahl
13 Jan 2022
Danish company filing
22 Dec 2021
Danish company filing
1 Jul 2021
Annual report for the year ending 31/12/2020
31 May 2021
Change of shareholdings: AbbVie Investments Sàrl · Voting rights: AbbVie Investments Sàrl
31 May 2021
Shareholder: AbbVie Central Finance B.V. · Voting rights: AbbVie Central Finance B.V
1 Sept 2020
Annual report for the year ending 31/12/2019
7 Jun 2019
Annual report for the year ending 31/12/2018
20 Mar 2019
Director: Thea Larsen · No longer Director: Ch. Dyreborg Jeppes
14 Mar 2019
No longer Director: Ch. Dyreborg Jeppes
14 Mar 2019
Director: Thea Larsen
7 Feb 2019
Member of the board: Thea Larsen · No longer Member of the board: Ch. Dyreborg Jeppes
29 Jan 2019
No longer Member of the board: Ch. Dyreborg Jeppes
29 Jan 2019
No longer Member of the board: Tom Schjødt
29 Jan 2019
No longer Chair of the board: William Joseph Chase
29 Jan 2019
Member of the board: Linn K. Mandahl
29 Jan 2019
Chair of the board: Robert A. Michael
29 Jan 2019
Member of the board: Thea Larsen
8 Jun 2018
Annual report for the year ending 31/12/2017
6 Jun 2017
Annual report for the year ending 31/12/2016
6 Jun 2016
Annual report for the year ending 31/12/2015
24 Jun 2015
Company statute
4 Jun 2015
Annual report for the year ending 31/12/2014
19 Dec 2014
Auditor: Ernst & Young P/S · No longer Auditor: Ernst & Young Denmark P/S
10 Oct 2014
Auditor: EY Godkendt P/S
10 Oct 2014
No longer Auditor: Ernst & Young Denmark P/S
6 Jun 2014
Annual report for the year ending 31/12/2013
12 Jun 2013
Auditor: Ernst & Young P/S · No longer Auditor: Ernst & Young Godkendt A/S
11 Jun 2013
Annual report for the year ending 31/12/2012
11 Jun 2013
Auditor: Ernst & Young Godkendt A/S · No longer Auditor: Deloitte Statsautoriseret P/S
7 Jun 2013
Auditor: Ernst & Young Denmark P/S
7 Jun 2013
No longer Auditor: Deloitte Statsautoriseret P/S
7 Jun 2013
Danish person filing
1 Jan 2013
Member of the board: William Joseph Chase · No longer Member of the board (1)
1 Jan 2013
No longer Chair of the board (1)
1 Jan 2013
Chair of the board: William Joseph Chase
1 Nov 2012
Change of shareholdings: AbbVie Investments Sàrl · Voting rights: AbbVie Investments Sàrl
1 Oct 2012
Capital: 501,000 DKK · Company statute
23 Aug 2012
Danish company filing
10 Apr 2012
Company statute
21 Mar 2012
Reg­is­tra­tion · Director: Christina Dyreborg · Member of the board (3) · Auditor: Deloitte Statsautoriseret P/S · Founder: WCA Pharmaceuticals Investments Sàrl · Capital: 500,000 DKK · Proxy policy
14 Mar 2012
Director: Ch. Dyreborg Jeppes · Member of the board: Ch. Dyreborg Jeppes
14 Mar 2012
Member of the board: Tom Schjødt
14 Mar 2012
Chair of the board (1)
14 Mar 2012
Founder: WCA Pharmaceuticals Investments Sàrl
14 Mar 2012
Auditor: Deloitte Statsautoriseret P/S
There are no publications matching your search.

Mentions

2 Apr 2024 in Ler
Direct parent
2 Apr 2024 in Ler
Ultimate parent
There are no publications matching your search.

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Printing is only available to North Data premium service subscribers.